← К результатам

JBRA Assist Reprod · 2021

Biotechnological challenges: The scope of genome editing.

JBRA assisted reproduction, 25(1): 150-154 PMID 32598833 DOI 10.5935/1518-0557.20200038

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debates and interdisciplinary discussions. This brings multiple challenges for both scientists and those who must regulate the use of these techniques.

Цитирование